Working... Menu
Trial record 2 of 27 for:    "Central Nervous System Lymphoma" | "Topoisomerase Inhibitors"

Treatment of Primary CNS Lymphoma (FVD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01960192
Recruitment Status : Recruiting
First Posted : October 10, 2013
Last Update Posted : July 21, 2015
Zhengzhou University
Information provided by (Responsible Party):
Mingzhi Zhang, Zhengzhou University

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2016
  Estimated Study Completion Date : June 2020